Chronic myelogenous leukemia and retinopathy treated with imatinib.


PURPOSE To describe a case of a rapid clinical response to treatment of leukemic retinopathy and optic nerve infiltration with cytoreductive therapy, including imatinib mesylate (Gleevec), without radiation therapy. METHODS Observational case report. RESULTS A 13-year-old boy presented with blurry vision and a visual acuity of 20/20 in each eye. On… (More)
DOI: 10.1097/ICB.0b013e31821cdf29